Sang‐Moo Kang

10.4k total citations
238 papers, 8.5k citations indexed

About

Sang‐Moo Kang is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Sang‐Moo Kang has authored 238 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Epidemiology, 138 papers in Immunology and 43 papers in Infectious Diseases. Recurrent topics in Sang‐Moo Kang's work include Influenza Virus Research Studies (126 papers), Respiratory viral infections research (103 papers) and Immune Cell Function and Interaction (67 papers). Sang‐Moo Kang is often cited by papers focused on Influenza Virus Research Studies (126 papers), Respiratory viral infections research (103 papers) and Immune Cell Function and Interaction (67 papers). Sang‐Moo Kang collaborates with scholars based in United States, South Korea and Canada. Sang‐Moo Kang's co-authors include Richard W. Compans, Fu‐Shi Quan, Mark R. Prausnitz, Jae-Min Song, Eun‐Ju Ko, Yeu‐Chun Kim, Dae‐Goon Yoo, Ki‐Hye Kim, Bao‐Zhong Wang and Young‐Tae Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Sang‐Moo Kang

236 papers receiving 8.3k citations

Peers

Countries citing papers authored by Sang‐Moo Kang

Since Specialization

Citations

This map shows the geographic impact of Sang‐Moo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Moo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Moo Kang more than expected).

Fields of papers citing papers by Sang‐Moo Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang‐Moo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Moo Kang. The network helps show where Sang‐Moo Kang may publish in the future.

Co-authorship network of co-authors of Sang‐Moo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Sang‐Moo Kang. A scholar is included among the top collaborators of Sang‐Moo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang‐Moo Kang. Sang‐Moo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Virus-like Particle Vaccines Containing RSV Fusion Protein Cleavage Mutations Are Immunogenic and Protective in Cotton Rats With a Prime Dose 2025 ·Immune Network ·Hye Suk Hwang, Young‐Man Kwon, (unknown), Young‐Tae Lee, Eun‐Ju Ko, (unknown), Sang‐Moo Kang	0
2	Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination 2025 ·Journal of Virology ·(unknown), Ki‐Hye Kim, (unknown), (unknown), (unknown), (unknown), (unknown), Rong Liu, Bao‐Zhong Wang, Sang‐Moo Kang	1
3	Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants 2024 ·Vaccines ·Rong Liu, Janhavi P. Natekar, Ki‐Hye Kim, Heather Pathak, (unknown), (unknown), Bo Ryoung Park, (unknown), Chong Hyun Shin, Mukesh Kumar, Sang‐Moo Kang	3
4	Metabolic reprograming and increased inflammation by cadmium exposure following early-life respiratory syncytial virus infection: the involvement of protein S-palmitoylation 2023 ·Toxicological Sciences ·(unknown), Choon‐Myung Lee, Ki‐Hye Kim, Xiaojia He, Matthew Ryan Smith, (unknown), (unknown), Michael Orr, Sang‐Moo Kang, (unknown), Dean P. Jones, Young‐Mi Go	7
5	Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses 2023 ·Vaccines ·Ipshita Menon, (unknown), Priyal Bagwe, (unknown), (unknown), Keegan Braz Gomes, Sang‐Moo Kang, Martin J. D’Souza	5
6	A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine 2022 ·npj Vaccines ·Subbiah Jeeva, (unknown), Ki‐Hye Kim, Chong Hyun Shin, Bo Ryoung Park, (unknown), Baik Lin Seong, Bao‐Zhong Wang, Sang‐Moo Kang	23
7	Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery 2022 ·Viruses ·Keegan Braz Gomes, Ipshita Menon, Priyal Bagwe, (unknown), Sang‐Moo Kang, Martin J. D’Souza	10
8	Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), Ki‐Hye Kim, Chong Hyun Shin, Bo Ryoung Park, (unknown), Yu‐Jin Jung, Youri Lee, Bao‐Zhong Wang, Baik Lin Seong, Sang‐Moo Kang	5
9	Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses 2022 ·Virology ·(unknown), Subbiah Jeeva, Ki‐Hye Kim, Bo Ryoung Park, (unknown), (unknown), Rong Liu, Yu‐Jin Jung, Chong Hyun Shin, Baik Lin Seong, Sang‐Moo Kang	2
10	Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity 2022 ·Vaccines ·(unknown), (unknown), (unknown), (unknown), Sang‐Moo Kang, Martin J. D’Souza	4
11	Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei 2022 ·Biomedicines ·(unknown), Ki‐Back Chu, Hae‐Ji Kang, (unknown), (unknown), (unknown), Su‐Hwa Lee, Subbiah Jeeva, Sang‐Moo Kang, Eun‐Kyung Moon, Fu‐Shi Quan	1
12	BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection 2021 ·Biomedicines ·Ki‐Hye Kim, Young‐Tae Lee, (unknown), Eun‐Ju Ko, Yu‐Jin Jung, Yu-Jin Kim, Eun‐Kyeong Jo, Sang‐Moo Kang	6
13	Commensal epitopes drive differentiation of colonic T _regs 2020 ·Science Advances ·Michal Kuczma, Edyta Szurek, Anna Cebula, Benoît Chassaing, Yu‐Jin Jung, Sang‐Moo Kang, James G. Fox, Bärbel Stecher, Leszek Ignatowicz	51
14	Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice 2020 ·Vaccine ·Yu‐Jin Jung, Ki‐Hye Kim, Eun‐Ju Ko, Youri Lee, Min‐Chul Kim, Young‐Tae Lee, Cheol-Hyun Kim, Subbiah Jeeva, Bo Ryoung Park, Sang‐Moo Kang	4
15	A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus 2019 ·Virology ·Youri Lee, Eun‐Ju Ko, Ki‐Hye Kim, Young‐Tae Lee, Hye Suk Hwang, Young‐Man Kwon, Barney S. Graham, Sang‐Moo Kang	11
16	Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles 2019 ·Vaccine ·Young‐Man Kwon, Youri Lee, (unknown), Yu Jin Jung, Zhuo Li, Subbiah Jeeva, Sujin Lee, Martin L. Moore, Sang‐Moo Kang	7
17	Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice 2019 ·Vaccine ·Eun‐Ju Ko, Youri Lee, Young‐Tae Lee, Yu‐Jin Jung, Vu L. Ngo, Min‐Chul Kim, Ki‐Hye Kim, Bao‐Zhong Wang, Andrew T. Gewirtz, Sang‐Moo Kang	9
18	Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection 2017 ·Biochemical and Biophysical Research Communications ·Yu-Jin Kim, Eun‐Ju Ko, Min‐Chul Kim, Yuna Lee, Ki‐Hye Kim, Yu‐Jin Jung, Sang‐Moo Kang	17
19	Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin 2015 ·Nanomedicine Nanotechnology Biology and Medicine ·Yuna Lee, Hye Suk Hwang, Min‐Chul Kim, Young‐Tae Lee, Yu-Jin Kim, F. Eun-Hyung Lee, Sang‐Moo Kang	6
20	Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus 2010 ·Proceedings of the National Academy of Sciences ·Jae-Min Song, Nico van Rooijen, Jadranka Bozja, Richard W. Compans, Sang‐Moo Kang	129

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact